We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 30

Pleading still matters: Shareholders failed to properly plead scienter

  • Bricker & Eckler LLP
  • -
  • USA
  • -
  • April 1 2014

Despite the complexities involved in securities fraud actions, the Sixth Circuit recently reminded litigants that adequately pleading facts to

2013 year-end Foreign Corrupt Practices Act update

  • Baker & Hostetler LLP
  • -
  • Libya, USA
  • -
  • February 10 2014

The third and fourth quarters of 2013 proved to be eventful and poten- tially prophetic as to the course the Foreign Corrupt Practices Act ("FCPA"

Last man standing

  • Cooley LLP
  • -
  • USA
  • -
  • December 27 2013

The Gentiva securities class action is based on allegations that the company violated Medicare rules and artificially inflated the Medicare payments

White collar roundup - April 2014

  • Day Pitney LLP
  • -
  • USA
  • -
  • April 1 2014

In United States v. Gupta the U.S. Court of Appeals for the Second Circuit affirmed the conviction of Rajat Gupta for his participation in the Raj

Scienter inadequately pled under the standard set forth in the PSLRA

  • Katten Muchin Rosenman LLP
  • -
  • USA
  • -
  • October 8 2010

The U.S. District Court for the Southern District of Indiana dismissed plaintiff’s securities fraud action against a nationwide health care benefits provider, and its officers and directors, in which plaintiff alleged that defendants artificially inflated the price of the stock by making certain false and misleading statements

SEC files another fraud action tied to the municipal bond market

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • September 15 2013

The SEC filed another settled financial fraud action tied to the municipal bond market which is clearly an area of increasing focus. This proceeding

Courts issue contrary rulings re statements touting compliance program

  • Jenner & Block
  • -
  • USA
  • -
  • June 5 2013

Two district courts recently reached different conclusions regarding whether investors may proceed on a securities fraud claim based in part on

U.S. Supreme Court rules that a drug’s adverse event reports may be material to investors even though not "statistically significant"

  • Jones Day
  • -
  • USA
  • -
  • March 28 2011

On March 22, 2011, the U.S. Supreme Court issued its long-awaited opinion in Matrixx Initiatives, Inc. v. Siracusano (No. 09-1156

Matrixx Securities fraud case could affect product liability law

  • Squire Sanders
  • -
  • USA
  • -
  • December 10 2010

Sometimes the most significant changes in the law come from unexpected places

First Circuit upholds dismissal of securities fraud action based upon immateriality of allegedly omitted information

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • July 27 2012

In In re Boston Scientific Corp. Securities Litigation, 2012 WL 2849660 (1st Cir. July 12, 2012), the United States Court of Appeals for the First Circuit affirmed the dismissal of a securities class action lawsuit against Boston Scientific Corporation (the “BSC”